Skip to main content
. 2021 Sep 27;70(12):2903–2916. doi: 10.2337/db21-0385

Figure 2.

Figure 2

Survival probability by cohort up to 28 days after the first record of COVID-19 (diagnosis code for COVID-19 or positive test results for SARS-CoV-2). A: All patients without T2DM (n = 200,293) and all patients with T2DM (n = 29,516). B: Patients in the drug comparison cohorts (No-G/D/P, n = 23,714; GLP-1R agonists, n = 1,774; DPP-4 inhibitors, n = 2,264; pioglitazone, n = 469; Any Med, n = 5,606).